ML18037A884

From kanterella
Revision as of 01:13, 18 May 2018 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
Nwmi Commission Hearing Exhibit List - Revision 2
ML18037A884
Person / Time
Site: Northwest Medical Isotopes
Issue date: 02/06/2018
From: Haass C C
Northwest Medical Isotopes
To:
NRC/OCM
SECY RAS
References
Construction Permit Mndtry Hrg, M 50-609-CP, RAS 54214
Download: ML18037A884 (4)


Text

Exhibit List-R2 Exhibit List (Docket No. 50-609-CP) 1 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION ) In the Matter of ) Docket No. 50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC ) ) (Medical Radioisotope Production Facility) ) February 6, 2018 ) EXHIBIT LIST (REVISION 2) NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING notice dated November 21, 2017 and Scheduling Order dated January 9, 2018, Northwest Medical Isotopes, LLC (NWMI) hereby submits its updated list of exhibits for the evidentiary hearing for Docket No. 50-609-CP held on January 23, 2018 (Revision 2). The updated list includes Exhibit NWMI-January 30, 2018 post-hearing questions regarding the mandatory hearing for the Construction . Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title. Exhibit Number Panel Number/ Sponsoring Witness(es) Document Description/Title NWMI-001-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses -Hearing Questions NWMI-002-R Carolyn C. Haass Northwest Medical Isotopes, LLC - Public Pre-Hearing Questions Exhibit List-R2 Exhibit List (Docket No. 50-609-CP) 2 Exhibit Number Panel Number/ Sponsoring Witness(es) Document Description/Title NWMI-003-R Statement of Qualifications: Roy W. Brown, Ralph A. Butler, Michael R. Corum, Gary L. Dunford, Nicholas F. Fowler, Carolyn C. Haass, Steve R. Reese Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application NWMI-004-R Overview Panel: Roy W. Brown, Nicholas F. Fowler, Carolyn C. Haass, Steve R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation NWMI-005-R Safety Panel 1: Ralph A. Butler, Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Steve R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation NWMI-006-R Safety Panel 2: Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Steve R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation NWMI-007-R Environmental Panel: Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Steve R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation NWMI-008 Letters of Support: U.S. Senators Ron Wyden and Claire McCaskill; Boone County Commissioner Dan Atwill; Manager, City of Columbia, Missouri, Mike Mathis; Missouri Department of Economic Development, Terrance M. Maglich, Project Manager Federal, State of Missouri, City of Columbia, and Boone County letters of support for the construction and operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility NWMI-009 Missouri Department of Natural Resources Letter to Northwest Medical Isotopes, LLC, dated September 15, 2017 Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189 NWMI-010 Northwest Medical Isotopes, LLC Letter (NWMI-LTR-2017-016) to U.S. Nuclear Regulatory Commission, dated December 18, 2017 Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing for Northwest Medical Isotopes, LLC Radioisotope Production NWMI-011-R Carolyn C. Haass -Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility NWMI-012 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses ost-Hearing Questions Exhibit List-R2 Exhibit List (Docket No. 50-609-CP) 3 Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado This 6th day of February 2018 Exhibit List-R2 Certificate of Service (Docket No. 50-609-CP) UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION ) In the Matter of ) Docket No. 50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC ) ) (Medical Radioisotope Production Facility) ) February 6, 2018 ) CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the (Revision 2), Northwest Medical Isotopes, LLC, Evidentiary HearingExhibits NWMI-013 were submitted through the NRC E-filing system. Exhibits NWMI-001-R through NWMI-011-R have not been revised since the original submission. Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 6th day of February 2018